Our data suggest that specific NKD1 mutations alter Wnt/β-catenin signaling in a minority of MSI-CRC as well as possibly in other β-catenin signal-dependent tumors in which mutations in the known Wnt regulators are infrequent. The gene discussed is NKD1; the disease is colorectal carcinoma.